NMDA受体自身抗体主要损害了超突触区
Zoe Jamet1, Camille Mergaux1, Morgane Meras1
1Interdisciplinary Institute for Neuroscience, IINS, UMR 5297, University of Bordeaux, CNRS, F-33000 Bordeaux, France.
Brain : a journal of neurology
|May 17, 2024
概括
对N-甲基-D-酸盐受体 (NMDAR-Ab) 的自身抗体最初会破坏突触蛋白,然后影响突触蛋白. 这项研究揭示了NMDAR-Ab在脑炎中的早期分子级联,影响神经元功能.
科学领域:
- 神经免疫学 神经免疫学
- 分子神经科学 分子神经科学
- 细胞生物学 细胞生物学
背景情况:
- 对N-甲基-D-酸盐受体 (NMDAR-Ab) 的自身抗体是NMDAR脑炎的关键,导致神经和精神症状.
- 通过NMDAR-Ab诱导大脑功能障碍的精确早期分子机制仍然不太了解.
- 现有的关于NMDAR-Ab在神经网络上的早期行动的知识是分散的.
研究的目的:
- 通过先进的成像,阐明NMDAR-Ab对活海马神经元的时空效应.
- 调查NMDAR-Ab.所启动的初始分子目标和级联.
- 为了区分NMDAR-Ab对超突触与突触NMDARs的影响.
主要方法:
- 在活的海马神经元上对膜蛋白的基于单个分子的成像.
- 对NMDAR膜动态和蛋白相互作用的分析.
- 研究EphB2受体在NMDAR-Ab中介作用中的作用.
主要成果:
- NMDAR-Ab主要针对外突触NMDAR,增加它们的膜动态,并在几分钟内将它们的相互作用组分离.
- NMDAR-Ab迅速改变了多重膜蛋白在超突触中的分布.
- 长期影响包括由于受体动态减慢而减少的突触NMDARs,独立于交叉链接.
- 单单针对异突触NMDARs就足以引起对突触受体的影响.
结论:
- NMDAR-Ab首先通过破坏突触蛋白来启动致病作用,随后影响突触组件.
- 这项研究为NMDAR-Ab.的早期作用模式提供了新的见解.
- 这些发现有助于理解NMDAR脑炎和相关的 (额外) 突触病理.
更多相关视频
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
9.9K
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
3.2K
相关概念视频
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...